IDH1 and neoplasm: Rather, they found that R-2HG increased the frequency of regulatory T cells (Tregs).38 Other studies concluded that R-2HG accumulation in IDH mutant tumors inhibits both CD8+ T cell function and anti-tumor activity.39–42